2nd Declaration of “Emergency State” for Mpox (Monkeypox) as Cases Rise in Japan: 248 Confirmed
- Moderna Latest Study: mRNA Therapy for Treating T Cell-Mediated Autoimmune Diseases
- The Biosecure Act May Hurt Pharmaceutical Supply Chains
- Mosquito Elimination on Global Health: Unraveling the Claim of 700K Annual Deaths
- Intensive Blood Pressure Management to Below 140 mmHg Reduces Stroke Risk, Regardless of Medication Dosage
- GLP-1 Drugs: How Significant is Their Impact on Brain Health?
- Why Eel Sashimi Is Unsafe: Understanding the Risks of Consuming Raw Eel
2nd Declaration of “Emergency State” for Mpox (Monkeypox) as Cases Rise in Japan: 248 Confirmed
- Shocking! All existing AIDS vaccine developments have failed
- Sanofi Japan Data Breach: 730000 Healthcare Professionals’ Information Exposed
- CT Radiation Exposure Linked to Blood Cancer in Children and Adolescents
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
2nd Declaration of “Emergency State” for Mpox (Monkeypox) as Cases Rise in Japan: 248 Confirmed
The World Health Organization (WHO) has declared a “Public Health Emergency of International Concern” for Mpox (formerly known as Monkeypox) for the second time since 2022.
This declaration, made on the 14th of this month, highlights the need for coordinated international efforts to save lives.
In Japan, outbreaks have continued since the first case was reported two years ago, with 248 cases confirmed so far.
Understanding Mpox (Monkeypox)
According to Japan’s Ministry of Health, Labour, and Welfare, Mpox is an infectious disease caused by the Mpox virus and is classified as a Class 4 infectious disease under Japan’s Infectious Disease Control Law. After an incubation period of typically 7 to 14 days, symptoms such as headaches, fever, swollen lymph nodes, and a rash with blisters may appear. These symptoms usually persist for 2 to 4 weeks, but most cases resolve naturally. The smallpox vaccine has been shown to be effective in preventing the onset of Mpox.
Transmission: Not Limited to Men
While Mpox has been notably linked to transmission among men who have sex with men (MSM), the virus can also infect women and children. Pregnant women and individuals with compromised immune systems are at higher risk of severe outcomes. In some regions of Africa, transmission has occurred through contact with infected rodents (such as squirrels or rats) or through the handling of their meat. Human-to-human transmission can occur through contact with bodily fluids, blood, sexual contact, or prolonged exposure to respiratory droplets at close range.
Japan reported its first Mpox case on July 25, 2022. In December last year, the Ministry of Health announced the death of a man in his 30s from Saitama Prefecture, who was HIV-positive and had no recent travel history, marking Japan’s first Mpox-related death. Sporadic cases continue to be reported in Japan this year.
Name Change and Its Implications
In May of last year, the name of the disease was officially changed from “Monkeypox” to “Mpox” due to concerns that the original name carried racial connotations and was misleading, as the virus has been found in a variety of animals beyond monkeys. This change was made to better reflect the disease’s reality and avoid reinforcing incorrect perceptions.
2nd Declaration of “Emergency State” for Mpox (Monkeypox) as Cases Rise in Japan: 248 Confirmed
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
